BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27402168)

  • 1. The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.
    Hurtado-de-Mendoza A; Jackson MC; Anderson L; Sheppard VB
    J Genet Couns; 2017 Feb; 26(1):113-121. PubMed ID: 27402168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods.
    Sheppard VB; Sutton AL; Hurtado-De-Mendoza A; Tariq F; Perera RA; Quillin J; Jeudy M; Gómez-Trillos S; Schwartz MD
    Contemp Clin Trials; 2023 Jul; 130():107210. PubMed ID: 37142159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of psychosocial factors in Black women's self-efficacy in receiving genetic counseling and testing.
    Ding H; Sutton AL; Hurtado-de-Mendoza A; Sheppard VB
    J Genet Couns; 2021 Dec; 30(6):1719-1726. PubMed ID: 34085362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
    Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
    Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
    BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
    Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
    Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Georgia Primary Care Providers' Knowledge of Hereditary Breast and Ovarian Cancer Syndrome.
    Nair N; Bellcross C; Haddad L; Martin M; Matthews R; Gabram-Mendola S; Crane B; Meaney-Delman D
    J Cancer Educ; 2017 Mar; 32(1):119-124. PubMed ID: 26637472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
    Conley CC; Kasting ML; Augusto BM; Garcia JD; Cragun D; Gonzalez BD; Kim J; Ashing KT; Knott CL; Hughes-Halbert C; Pal T; Vadaparampil ST
    Ann Surg Oncol; 2020 May; 27(5):1659-1670. PubMed ID: 31677107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black Women's Confidence in the Genetic Information Nondiscrimination Act.
    Sutton AL; Henderson A; Hurtado-de-Mendoza A; Tanner E; Khan M; Quillin J; Sheppard VB
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
    Sheppard VB; Mays D; LaVeist T; Tercyak KP
    J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.
    Kessler L; Domchek S; Stopfer J; Halbert CH
    Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items.
    Scherr CL; Christie J; Vadaparampil ST
    Public Health Genomics; 2016; 19(1):1-10. PubMed ID: 26389838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
    Armstrong K; Micco E; Carney A; Stopfer J; Putt M
    JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counseling and testing for breast cancer risk in African Americans.
    Halbert CH
    LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic Counseling of HBOC and Japanese Organization of HBOC].
    Fukushima Y
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):107-110. PubMed ID: 28223668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    Ademuyiwa FO; Salyer P; Tao Y; Luo J; Hensing WL; Afolalu A; Peterson LL; Weilbaecher K; Housten AJ; Baumann AA; Desai M; Jones S; Linnenbringer E; Plichta J; Bierut L
    J Clin Oncol; 2021 Dec; 39(36):4020-4028. PubMed ID: 34662201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.